NewAge Industries, Inc. and Carolina Components Group, Inc. have announced a strategic partnership aimed at co-developing and co-marketing environmentally responsible products for the single-use biopharma manufacturing sector. The collaboration seeks to address growing industry demands for sustainable manufacturing solutions that reduce carbon footprints and align with evolving regulatory requirements.
The initial focus of the partnership will be developing a line of Thermoplastic Elastomer (TPE) tubing products designed to help manufacturers achieve their greenhouse gas reduction targets. This initiative represents a significant step toward creating more environmentally conscious manufacturing processes in the biopharma industry.
Mary Marcus, CEO of NewAge Industries, emphasized the importance of sustainability in their current market landscape. The company's existing Gold Ecovadis rating underscores their commitment to sustainable practices and positions them as a leader in environmental responsibility within the fluid transfer systems sector.
John Cooling, President and CEO of Carolina Components Group, highlighted the mutual commitment to sustainability that drove the partnership. By combining their expertise, the two companies aim to introduce innovative, eco-friendly tubing materials that can help manufacturers make more sustainable purchasing decisions.
The collaboration addresses a critical need in the biopharma manufacturing industry, where companies are increasingly seeking solutions that support their environmental sustainability goals. By developing products with reduced carbon footprints, NewAge Industries and Carolina Components Group are positioning themselves at the forefront of a growing trend toward more environmentally responsible manufacturing practices.
This partnership is particularly significant given the increasing global focus on reducing industrial greenhouse gas emissions and transitioning toward a more circular economy. The proposed TPE tubing products represent a tangible approach to addressing these broader environmental challenges within the specialized biopharma manufacturing equipment market.
The joint effort demonstrates how strategic collaborations can drive innovation in sustainability, allowing companies to meet emerging market demands while contributing to broader environmental conservation efforts. As regulatory pressures and consumer expectations continue to evolve, partnerships like this one will likely become increasingly important in transforming industrial manufacturing practices.
